Canntab Therapeutics Limited Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2022
January 26, 2023 at 01:19 pm
Canntab Therapeutics Limited reported earnings results for the second quarter and six months ended November 30, 2022. For the second quarter, the company reported net loss was CAD 1.03 million compared to CAD 1.22 million a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.04 a year ago.
For the six months, net loss was CAD 1.5 million compared to CAD 1.83 million a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.05 a year ago.